Wudi Reaction Pharma&chemical Co., Ltd.

Country/Region: China     State/Province: Shandong

Main Products: Wudi Reaction Pharma&ampampChemical Co., Ltd., Wudi Reaction Pharma&ampampChemical Co.

Location: Xinhai Industrial Zone, Wudi County, Shandong Province, China. Binzhou Heilongjiang ***, Xinhai Industrial Zone,Wudi County,Shandong Province, China.

Company Introduction
Wudi Reaction Pharma&Chemical Co., Ltd. Private Limited started off as a leading Manufacturer and Supplier of Sitagliptin. Since inception, our production facility has marked perfection in terms of quality and reliability of Wudi Reaction Pharma&ampChemical Co.,Ltd., delivered worldwide. Wudi Reaction Pharma&Chemical Co., Ltd. was inaugurated back in 2007 with Above US$100 Million initial business capital, holding export history over 13 Years .Construction equipment and material demands finest quality in terms of make and aesthetic appeal and by successfully complying with industrial demand we have reached Approx More Than 1 Billion US Dollar annual revenue and Australia,Canada,Germany,France,United Kingdom export market share. We take pride in our credibility, operating with a Have Own Export License in Binzhou, Heilongjiang, China.Our corporate venture follows strict quality control procedures, thanks to state of the art equipment and skilled professionals. With years of experience we have mastered the art of developing finest quality products with sourcing raw material that guarantees reliability and years of service. For product queries and pricing details contact olivia.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2007, 2007

Legal Status: Have Own Export License

Ownership: Private Limited

Employees: 101 - 200 People

Factory Size: Above 100, 000 square meters

R&D Team Size: 51 - 100 People

Certifications: SA8000

Contact Information

Contact Person: olivia

Designation: Manager

Department: Overseas Team

Telephone: 86-15306493269

Business Information

Main Markets: United Kingdom (25%) Germany (23%) Canada (20%) Australia (11%) France (11%)

Export Focus: Australia, Canada, Germany, France, United Kingdom

Contract Services: Design Service Offered

Trade & Financial Information

Annual Revenue: Approx More Than 1 Billion US Dollar

Registered Capital: Above US$100 Million

Export Percentage: 21% - 30%

Payment Terms: Bank wire (T/T), Letter of Credit (L/C), Credit Card (CC), PayPal

Product Showcase
Wudi Reaction Pharma&ampampChemical Co.
Ltd.
Wudi Reaction Pharma&ampampChemical Co.
Ltd.

CL-Link > Health & Medicines in China Health & Medicines in Shandong Medicines in China Medicines in Shandong Sitagliptin in China Sitagliptin in Shandong